Democrats demand unredacted drug pricing agreements from pharma firms after midterm victories

Congressional Democrats have intensified scrutiny of pharmaceutical pricing agreements made under the previous administration.

On Monday they sent letters to every drug maker that entered a most favored nation pricing deal with the Trump administration, asking for the full, unredacted contracts.

The move follows the party's recent gains in the midterm elections and reflects a broader push to increase transparency and potentially renegotiate terms that affect Medicare and other public payers.